• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合细胞因子受体可在白细胞介素6受体α(IL-6Rα)、IL-11Rα和gp130低表达至阴性的原始造血祖细胞中传导扩增信号。

Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.

作者信息

Takagi M, Nakamura T, Sawada T, Kaneko A, Nozaki-Ukai M, Nakahata T, Yokota T, Heike T

机构信息

Department of Stem Cell Regulation, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

出版信息

Mol Biol Cell. 1999 Nov;10(11):3633-42. doi: 10.1091/mbc.10.11.3633.

DOI:10.1091/mbc.10.11.3633
PMID:10564261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC25652/
Abstract

We generated transgenic mice expressing chimeric receptors, which comprise extracellular domains of the human granulocyte-macrophage colony-stimulating factor (hGM-CSF) receptor and transmembrane and cytoplasmic domains of the mouse leukemia inhibitory factor receptor. In suspension cultures of lineage-negative (Lin(-)), 5-fluorouracil-resistant bone marrow cells of the transgenic mice, a combination of hGM-CSF and stem cell factor (SCF) induced exponential expansions of mixed colony-forming unit. The combination of hGM-CSF and SCF was effective on enriched, Lin(-)Sca-1(+)c-kit(+) progenitors and increased either mixed colony-forming unit or cobblestone area-forming cells. In case of stimulation with hGM-CSF and SCF, interleukin-6 (IL-6) and SCF, or IL-11 and SCF, the most efficient expansion was achieved with hGM-CSF and SCF. When Lin(-)Sca-1(+)c-kit(+)CD34(-) further enriched progenitors were clone sorted and individually incubated in the presence of SCF, hGM-CSF stimulated a larger number of cells than did IL-6, IL-6 and soluble IL-6 receptor (IL-6R), or IL-11. These data suggest the presence of IL-6Ralpha-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors. Such primitive progenitors are equipped with signal transduction molecules and can expand when these chimeric receptors are genetically introduced into the cells and stimulated with hGM-CSF in the presence of SCF.

摘要

我们培育了表达嵌合受体的转基因小鼠,该嵌合受体包含人粒细胞-巨噬细胞集落刺激因子(hGM-CSF)受体的胞外结构域以及小鼠白血病抑制因子受体的跨膜和胞质结构域。在转基因小鼠的谱系阴性(Lin(-))、5-氟尿嘧啶抗性骨髓细胞的悬浮培养中,hGM-CSF和干细胞因子(SCF)的组合诱导了混合集落形成单位的指数扩增。hGM-CSF和SCF的组合对富集的Lin(-)Sca-1(+)c-kit(+)祖细胞有效,并增加了混合集落形成单位或鹅卵石区域形成细胞。在用hGM-CSF和SCF、白细胞介素-6(IL-6)和SCF或IL-11和SCF刺激的情况下,hGM-CSF和SCF实现了最有效的扩增。当对Lin(-)Sca-1(+)c-kit(+)CD34(-)进一步富集的祖细胞进行克隆分选并在SCF存在下单独培养时,hGM-CSF刺激的细胞数量比IL-6、IL-6和可溶性IL-6受体(IL-6R)或IL-11刺激的细胞数量更多。这些数据表明存在IL-6Rα-、IL-11Rα-以及gp130低至阴性的原始造血祖细胞。这种原始祖细胞配备有信号转导分子,当这些嵌合受体被基因导入细胞并在SCF存在下用hGM-CSF刺激时能够扩增。

相似文献

1
Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.嵌合细胞因子受体可在白细胞介素6受体α(IL-6Rα)、IL-11Rα和gp130低表达至阴性的原始造血祖细胞中传导扩增信号。
Mol Biol Cell. 1999 Nov;10(11):3633-42. doi: 10.1091/mbc.10.11.3633.
2
A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors.一种使用嵌合细胞因子受体实现胚胎干细胞自我更新的选择性开启系统。
Biochem Biophys Res Commun. 1998 Jul 9;248(1):22-7. doi: 10.1006/bbrc.1998.8900.
3
Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.白血病抑制因子对造血祖细胞生长的直接协同效应:与其他使用gp130受体亚基的造血因子的比较。
Blood. 1996 Aug 1;88(3):863-9.
4
Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.检测骨髓基质/成骨细胞中白细胞介素-6、白细胞介素-11、白血病抑制因子、制瘤素M和睫状神经营养因子的受体
J Clin Invest. 1996 Jan 15;97(2):431-7. doi: 10.1172/JCI118432.
5
Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.可溶性白细胞介素(IL)-6受体(R)和IL-6或IL-6R/IL-6融合蛋白激活gp130所产生的信号增强了人外周血来源造血祖细胞的体外扩增。
Stem Cells. 2000;18(6):444-52. doi: 10.1634/stemcells.18-6-444.
6
Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.人CD34+细胞白细胞介素6受体和gp130表达及增殖能力分析。
J Exp Med. 1996 Oct 1;184(4):1357-64. doi: 10.1084/jem.184.4.1357.
7
The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.人白细胞介素-11受体信号传导需要gp130:通过受体的分子克隆证明
Oncogene. 1996 Feb 1;12(3):585-93.
8
Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro.白细胞介素(IL)-11受体在人子宫内膜中的体内表达以及IL-11、IL-6和白血病抑制因子(LIF)对人子宫内膜细胞体外基质金属蛋白酶(MMP)和细胞因子产生的影响。
Mol Hum Reprod. 2002 Sep;8(9):841-8. doi: 10.1093/molehr/8.9.841.
9
Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.通过gp130、c-kit和白细胞介素-3受体同时激活信号,在缺乏终末作用的谱系特异性因子的情况下促进三系血细胞生成。
Blood. 1997 Dec 15;90(12):4767-78.
10
Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells.白血病抑制因子受体和gp130胞质结构域内的多个区域在肝细胞和神经元细胞的信号转导中协同作用。
Mol Cell Biol. 1994 Jan;14(1):138-46. doi: 10.1128/mcb.14.1.138-146.1994.

引用本文的文献

1
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development.用细胞因子和其他物质武装 CAR-T 细胞:第四代 CAR-T 开发的创新。
Mol Ther. 2023 Nov 1;31(11):3146-3162. doi: 10.1016/j.ymthe.2023.09.021. Epub 2023 Oct 5.
2
STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?激活 STAT3 的细胞因子:炎症性肠病的治疗契机?
J Interferon Cytokine Res. 2015 May;35(5):340-50. doi: 10.1089/jir.2014.0225. Epub 2015 Mar 11.

本文引用的文献

1
A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors.一种使用嵌合细胞因子受体实现胚胎干细胞自我更新的选择性开启系统。
Biochem Biophys Res Commun. 1998 Jul 9;248(1):22-7. doi: 10.1006/bbrc.1998.8900.
2
Interleukin 6 and its receptor: ten years later.白细胞介素6及其受体:十年之后。
Int Rev Immunol. 1998;16(3-4):249-84. doi: 10.3109/08830189809042997.
3
Stat1 associates with c-kit and is activated in response to stem cell factor.信号转导和转录激活因子1(Stat1)与原癌基因c-kit相关联,并在对干细胞因子的反应中被激活。
Biochem J. 1997 Oct 1;327 ( Pt 1)(Pt 1):73-80. doi: 10.1042/bj3270073.
4
In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK-2 ligand and KIT ligand.造血祖细胞的体外扩增及干细胞的维持:Flt3/Flk-2配体与KIT配体的比较
Blood. 1997 Mar 15;89(6):1915-21.
5
Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice.白细胞介素(IL)-6-可溶性IL-6受体双转基因小鼠中造血祖细胞的髓外扩增。
J Exp Med. 1997 Feb 17;185(4):755-66. doi: 10.1084/jem.185.4.755.
6
Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.人CD34+细胞白细胞介素6受体和gp130表达及增殖能力分析。
J Exp Med. 1996 Oct 1;184(4):1357-64. doi: 10.1084/jem.184.4.1357.
7
Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.截短的促红细胞生成素受体转基因控制多能造血细胞的增殖。
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9402-7. doi: 10.1073/pnas.93.18.9402.
8
Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma.创伤后通过上调白细胞介素(IL)6和IL - 6受体的表达促进小鼠神经再生
J Exp Med. 1996 Jun 1;183(6):2627-34. doi: 10.1084/jem.183.6.2627.
9
Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.单个低/阴性CD34造血干细胞的长期淋巴细胞造血重建。
Science. 1996 Jul 12;273(5272):242-5. doi: 10.1126/science.273.5272.242.
10
Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow.使用干细胞因子和白细胞介素-11进行体外扩增,可增强移植后的短期恢复能力以及连续移植骨髓的能力。
Blood. 1996 Jun 1;87(11):4589-95.